Humor

https://www.biolink.com/grand-opening-of-bio-link-chromatography-resin-manufacturing-site-phase-ii-boosting-annual-production-capacity-to-120000-liters.html
On June 30, 2023, the commissioning ceremony of the BioLink Chromatographic Chromatography Resin Manufacturing Site Phase II was successfully held in Lanzhou, Gansu Province, China. Since its establishment, BioLink has been dedicated to the research, development, and manufacturing of key process equipment and consumables for recombinant protein drugs, vaccines, antibody drugs, cell therapies, gene therapies, and other biopharmaceutical products. The product range covers upstream bioprocess cell culture, disposable liquid handling and downstream processes such as chromatography, ultrafiltration, and filtration units, as well as process development services.